Cabazitaxel in patients with advanced solid tumours: Results of a Phase I and pharmacokinetic study
Authors:
- V. DiérasVDV. Diéras
- A. LortholaryALA. Lortholary
- V. LaurenceVLV. Laurence
- R. DelvaRDR. Delva
- V. GirreVGV. Girre
- A. LivartowskiALA. Livartowski
- S. AssadourianSAS. Assadourian
- D. SemiondDSD. Semiond
- J.Y. PiergaJPJ.Y. Pierga
- 1 January 2013
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 49 (1) , 25-34
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Overcoming Chemotherapy Resistance in Prostate CancerClinical Cancer Research, 2011
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trialThe Lancet, 2010
- Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid TumorsClinical Cancer Research, 2009
- A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patientsAnnals of Oncology, 2008
- Paclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation TaxanesChemMedChem, 2007
- 2006 Update of ASCO Practice Guideline Recommendations for the Use of White Blood Cell Growth Factors: Guideline SummaryJournal of Oncology Practice, 2006
- Accelerated Titration Designs for Phase I Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1997
- A population pharmacokinetic model for docetaxel (Taxotere®): Model building and validationJournal of Pharmacokinetics and Biopharmaceutics, 1996
- The taxoids: paclitaxel and docetaxelThe Lancet, 1994
- Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulatorsJournal of Biological Chemistry, 1993